22 min listen
Therapy In Limbo: The FDA's MDMA Decision & What Went Wrong
Therapy In Limbo: The FDA's MDMA Decision & What Went Wrong
ratings:
Length:
25 minutes
Released:
Jun 19, 2024
Format:
Podcast episode
Description
Key advisers to the U.S. Food and Drug Administration (FDA) advised against approval for MDMA therapy for PTSD patients last week, questioning the drug’s sponsor, Lykos Therapeutics, on their results.
The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee.
Follow Kennedy on Twitter: @KennedyNation
Kennedy Now Available on YouTube: https://bit.ly/4311mhD.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The CEO of Lykos Therapeutics Amy Emerson shares her frustration with the disapproval and details what went wrong with the evaluation of the FDA advisory committee.
Follow Kennedy on Twitter: @KennedyNation
Kennedy Now Available on YouTube: https://bit.ly/4311mhD.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Jun 19, 2024
Format:
Podcast episode
Titles in the series (100)
Kennedy Saves Your Boobs: On this episode, Kennedy sits down with, Fox Business Anchor and Personal Finance Correspondent, Gerri Willis, for Breast Cancer Awareness Month to discuss the importance of checking your breasts and getting routine mammograms. Gerri shares with Kennedy the unexpected impact that having Stage 3 Breast Cancer had on her life. Follow Kennedy on Twitter: @KennedyNation by Kennedy Saves the World